Title: Pituitary Tumours: A Brief Review
Authors: Himanshu Mishra, Ritusha Mishra
DOI: https://dx.doi.org/10.18535/jmscr/v5i1.13
Abstract
Pituitary tumours are mostly benign tumours which constitute 10-20 % of all intracranial tumours. These may be functional (hormone secreting) or non-functional. The etiology of pituitary tumours is unknown. Incidence is common in 3rd to 5th decade of life with more predilection towards female. The frequency of various types of adenomas may vary according to type of hormone secretion, age and gender. Functional tumours produce clinical symptoms both because of hormonal dysregulation and mass effect while non-functional manifest through mass effect only. Magnetic Resonance Imaging (MRI) is imaging modality of choice. Combined modality treatment is required in the management.
Keywords- Pituitary, Surgical resection, Stereotactic Radiosurgery.
References
1. 1. Mindermann T, Wilson CB: Age-related and gender-related occurrence of pituitary adenomas. Clin Endocrinol (Oxf) 1994; 41:359-364.
2. Molitch ME: Pathologic hyperprolactin-emia. Endocrinol Metab Clin North Am 1992; 21:877-901.
3. Webster J, Piscitelli G, Polli A, et al: A comparison of cabergoline and bromocri-ptine in the treatment of hyperprolac-tinemic amenorrhea. Cabergoline Comp-arative Study Group. N Engl J Med 1994; 331:904-909
4. Schade R, Andersohn F, Suissa S, et al: Dopamine agonists and the risk of cardiac-valve regurgitation. N Engl J Med 2007; 356:29-38
5. Zanettini R, Antonini A, Gatto G, et al: Valvular heart disease and the use of dopamine agonists for Parkinson's disease. N Engl J Med 2007; 356:39-46.
6. Pouratian N, Sheehan J, Jagannathan J, et al: Gamma knife radiosurgery for medic-ally and surgically refractory prolactino-mas. Neurosurgery 2006; 59:255-266.
7. Castinetti F, Nagai M, Morange I, et al: Long-term results of stereotactic radios-urgery in secreatory pituitary adenomas, J Clin Endocrinol Metab 94:3400-3407, 2009
8. Colao A, Ferone D, Marzullo P, et al: Systemic complications of acromegaly: epidemiology, pathogenesis, and manage-ment. Endocr Rev 2004; 25:102-152.
9. Katznelson L: Diagnosis and treatment of acromegaly. Growth Horm IGF Res 2005.
10. Fahlbusch R, Honegger J, Buchfelder M: Surgical management of acromegaly. Endocrinol Metab Clin North Am 1992; 21:669-692.
11. Nomikos P, Buchfelder M, Fahlbusch R: The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical “cure”. Eur J Endocrinol 2005; 152:379-387.
12. Erturk E, Tuncel E, Kiyici S, et al: Outcome of surgery for acromegaly Perfo-rmed by different surgeons. Importance of surgical experience, Pituitary 8:93-97, 2005.
13. Freda PU, Katznelson L, van der Lely AJ, et al: Long-acting somatostatin analog therapy of acromegaly: a meta-analysis. J Clin Endocrinol Metab 2005.
14. van der Lely AJ, Hutson RK, Trainer PJ, et al: Long-term treatment of acromegaly with pegvisomant, a growth hormone rece-ptor antagonist. Lancet 2001; 358:1754-1759.
15. Jenkins PJ, Bates P, Carson MN, et al: Conventional pituitary irradiation is effective in lowering serum growth hormone and insulin-like growthfactor-I in patients with acromegaly, J Clin Endocrinol Metab 91:1239-1245,2006.
16. Pollock BE, Jacob JT, Brown PD, et al: Radiosurgery of growth hormonepro-ducing pituitary adenomas. Factors associated with biochemical remission, J Neurosurg 106:833-838, 2007.
17. Jagannathan J, Pouratian N, Laws ER Jr, et al: Gamma knife radiosurgery for acrome-galy: outcomes after failed transsphenoidal surgery, Neurosurgery 62:1262-1270, 2008.
18. Biller BM, Grossman AB, Stewart PM, et al: Treatment of adrenocorticotropin depe-ndent Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab 2008; 93:2454-2462.
19. De Tommasi C, Vance ML, Okonkwo DO, et al: Surgical management of adrenoco-rticotropic hormone-secreting macroad-enomas: outcome and challenges in patients with Cushing's disease or Nelson's syndr-ome. J Neurosurg 2005; 103:825- 830.
20. Patil CG, Prevedello DM, Lad SP, et al: Late recurrences of Cushing's disease after initial successful transsphenoidal surgery. J Clin Endocrinol Metab 2008; 93:358-362.
21. Minniti G, Osti M, Jaffrain-Rea ML, et al: Long-term follow-up results of postoper-ative radiation therapy for Cushing’s disease, J Neurooncol 84:79-84, 2007.
22. Höybye C, Grenbäck E, Rähn T, et al: Adrenocorticotropic hormone producing pituitary tumors: 12- to 22-year follow-up after treatment with stereotactic radiosur-gery, Neurosurgery 49:284-292, 2001.